SCHEMBL9979846

SCHEMBL9979846

Nc1ncnn2cc(C(=O)C=O)c(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4I)c(F)c3)c12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FLT3 P36888 5/20 0.46
FGFR1 P11362 4/20 0.46
RET P07949 3/20 0.46
FRK P42685 3/20 0.46
MAPK9 P45984 3/20 0.46
RPS6KA3 P51812 3/20 0.46
MAP4K2 Q12851 3/20 0.46
PRKCD Q05655 2/20 0.46
BCR P11274 1/20 0.46
DDR1 Q08345 1/20 0.46
TNK1 Q13470 1/20 0.46
RPS6KA1 Q15418 1/20 0.46
MAP3K11 Q16584 1/20 0.46
DDR2 Q16832 1/20 0.46
RPS6KA6 Q9UK32 1/20 0.46
KDR P35968 8/20 0.39
FLT1 P17948 7/20 0.39
CSF1R P07333 5/20 0.39
KIT P10721 5/20 0.39
FLT4 P35916 5/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10272908 0.87 FLT3 (0.48) FLT3FGFR1RETFRKMAPK9
SCHEMBL276514 0.85 FLT3 (0.53) FLT3FGFR1RETFRKMAPK9
SCHEMBL328019 0.84 FLT3 (0.46) FLT3FGFR1RETFRKMAPK9
SCHEMBL3622342 0.84 FLT3 (0.55) FLT3FGFR1RETFRKMAPK9
SCHEMBL3622289 0.83 FLT3 (0.54) FLT3FGFR1RETFRKMAPK9
SCHEMBL10272897 0.82 FGFR1 (0.46) FLT3FGFR1RETFRKMAPK9
SCHEMBL275169 0.82 FLT3 (0.53) FLT3FGFR1RETFRKMAPK9
SCHEMBL10225555 0.82 RET (0.48) FLT3FGFR1RETFRKMAPK9
SCHEMBL3621709 0.81 FGFR1 (0.52) FLT3FGFR1RETFRKMAPK9
SCHEMBL277013 0.80 FGFR1 (0.54) FLT3FGFR1RETFRKMAPK9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2465505-A1 Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Bayer HealthCare LLC (US) 2012-06-20 EP disclosed